P2.06-017 Amethyst NSCLC Trial: Phase 2 Study of MGCD265 in Patients with Advanced or Metastatic NSCLC with Activating Genetic Alterations in MET: Topic: Phase II + NKLyudmila Bazhenova,Dong-Wan Kim,Luigi Cavanna,Ji-Youn Han, Jongseok Lee,Hoon-Kyo Kim,Byoung Chul Cho,Marshall T. Schreeder,Ashiq Masood,Igor I. Rybkin,Melissa Lynne Johnson,Britt Boleman,Marta Batus,Estelamari Rodriguez,David S. Hong,Pasi A. Jänne,Raul Mena,F. Cappuzzo,Ivor Percent,Vanessa Tassell,James Christensen,Demiana Faltaos,Richard C. Chao,Hirak Der-Torossian,Diane Potvin,Ranee MehraJournal of Thoracic Oncology（2017）引用 5|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
